Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

688526.SS Gross Margin

The Gross Margin of Wuhan Keqian Biology Co Ltd (688526.SS) is 70.61%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

688526.SS Gross Margin - Historical Value
Date Value
2023-12-31 70.61%
2022-12-31 72.87%
2021-12-31 79.74%
2020-12-31 82.57%
2019-12-31 78.86%
2018-12-31 84.28%
2017-12-31 84.42%
688526.SS Gross Margin - Peers Comparison
Ticker Name Value
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 84.12%
300119.SZ Tianjin Ringpu Bio-Technology Co Ltd 40.73%
603229.SS Zhejiang Ausun Pharmaceutical Co Ltd 54.40%
603567.SS HeiLongJiang ZBD Pharmaceutical Co Ltd 42.01%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 91.05%
1477.HK Ocumension Therapeutics 53.93%
300630.SZ Hainan Poly Pharm Co Ltd 72.65%
300723.SZ ApicHope Pharmaceutical Co Ltd 81.04%
460.HK Sihuan Pharmaceutical Holdings Group Ltd 65.32%
603566.SS Pulike Biological Engineering Inc 60.76%
603718.SS Shanghai Hile Bio-Technology Co Ltd 48.68%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd 9.13%
002332.SZ Zhejiang Xianju Pharmaceutical Co Ltd 52.18%
300702.SZ Zhejiang Tianyu Pharmaceutical Co Ltd 33.63%
605199.SS Hainan Huluwa Pharmaceutical Group Co Ltd 52.35%
002424.SZ Guizhou Bailing Group Pharmaceutical Co Ltd 54.19%
300363.SZ Porton Pharma Solutions Ltd 23.33%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 76.81%
600851.SS Shanghai Haixin Group Co Ltd 46.37%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 23.12%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 73.17%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd 89.12%
000623.SZ Jilin Aodong Pharmaceutical Group Co Ltd 48.73%
002275.SZ Guilin Sanjin Pharmaceutical Co Ltd 72.25%
002626.SZ Xiamen Kingdomway Group Co 38.33%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 58.25%
300497.SZ Jiangxi Fushine Pharmaceutical Co Ltd 8.72%
300765.SZ CSPC Innovation Pharmaceutical Co Ltd 41.83%